Fig. 3From: Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinomaKaplan–Meier survival curves of cholangiocarcinoma patients with high or low expressions of UBE2C. A Overall survival, B disease-specific survival, C local recurrence-free survival, and D metastasis-free survivalBack to article page